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Evoked or experimental pain is often used as a model for the study of clinical pain, yet there are little data regarding the rela-
tionship between the two. In addition, there are few data regarding the types of stimuli and stimulus intensities that are most closely
related to clinical pain.
In this study, 36 subjects with ﬁbromyalgia (FM), chronic fatigue syndrome (CFS), or both syndromes were administered mea-
sures of clinical pain and underwent a dolorimetry evaluation. Subjects also underwent experimental pain testing utilizing heat and
pressure stimulation. Stimulation levels evoking low, moderate and high sensory intensity, and comparable levels of unpleasantness,
were determined for both types of stimuli using random staircase methods. Clinical pain was assessed using visual analogue ratings
and the short form of the McGill Pain Questionnaire (MPQ).
Ratings of heat pain sensation were not signiﬁcantly associated with clinical pain ratings, with the exception of unpleasantness
ratings at high stimulus intensities. Pain threshold and tolerance as assessed by dolorimetry were signiﬁcantly associated with aver-
age measures of clinical pain. Both intensity and unpleasantness ratings of pressure delivered using random staircase methods were
signiﬁcantly associated with clinical pain at low, moderate and high levels, and the strength of the association was greater at increas-
ingly noxious stimulus intensities.
These ﬁndings suggest that random pressure stimulation as an experimental pain model in these populations more closely reﬂects
the clinical pain for these conditions. These ﬁndings merit consideration when designing experimental studies of clinical pain asso-
ciated with FM and CFS.
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rights reserved.
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Experimental studies designed to deliver noxious
stimuli to subjects under controlled conditions are fre-
quently used to make inferences about clinical pain con-
ditions. Despite this, little is known about theAssociation for the Study of Pain. Published by Elsevier Ltd. All rights
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clinical pain, and there is a lack of research on the exper-
imental methods and types of stimuli that are most
highly associated with clinical pain (Gracely, 1999).
Such studies are highly important as evoked pain is
increasingly being used to study central nervous system
(CNS) abnormalities associated with clinical pain condi-
tions such as ﬁbromyalgia (FM), temporomandibular
disorders, vulvodynia, and other entities (Geisser et al.,
2003; Giesecke et al., 2004; Diatchenko et al., 2005; Pet-
zke et al., 2003a). While pain is not a central feature of
chronic fatigue syndrome (CFS), ﬁve of eight minor cri-
teria (of which four are necessary to make the diagnosis)
for CFS are pain-based (Fukuda et al., 1994). Common
CNS abnormalities have been proposed to underlie all
of these disorders (Clauw and Chrousos, 1997), and
determining the experimental methods that best repro-
duce the clinical abnormalities associated with these
conditions is crucial to their study.
Previous research has shown that persons with FM
display heightened responsiveness to auditory tones
(McDermid et al., 1996), contact thermal heat in both
the noxious and innocuous ranges (Geisser et al., 2003;
Kosek et al., 1996; Kosek and Hansson, 1997; Lautenb-
acher et al., 1994; Staud et al., 2001), ischemic pain
(Kosek and Hansson, 1997), pressure applied to the
thumb (Gracely et al., 2002; Petzke et al., 2003a) and
electrical stimulation (Lautenbacher et al., 1994). Diﬀer-
ences between FM subjects and controls have also been
observed using methodologies that stimulate abnormal
temporal summation of pain or wind-up (Staud et al.,
2001, 2003) and the regulation of diﬀuse noxious inhib-
itory controls (Kosek and Hansson, 1997). However,
only a few studies have examined how these abnormal-
ities relate to the experience of clinical pain. Lautenb-
acher et al. (1994) reported low associations between
measures of clinical pain and responses to electrocutane-
ous stimuli, pressure and heat. The authors also found
that pressure pain thresholds at two sites were signiﬁ-
cantly associated with clinical pain. Staud et al. (2003)
found that a combination of variables including mea-
sures of wind-up, pain-related negative aﬀect, and ten-
der point counts accounted for 49% of the variance in
clinical pain. Further research is needed to determine
the types of stimuli and experimental methods that are
most highly associated with clinical pain states. In addi-
tion, previous research suggests that experimental meth-
ods that employ gradually ascending stimulation are
more highly associated with psychological factors that
may bias pain ratings (Petzke et al., 2003).
In the present study, we examined the relationships
between clinical pain and a variety of evoked pain mea-
sures including gradually ascending pressure (dolorime-
try) and a random staircase method of stimulus
presentation of both pressure and heat stimuli. Based
on prior research, we hypothesized that the randomstaircase methods would be more highly associated with
measures of clinical pain compared to dolorimetry. In
addition, we hypothesized that pressure pain perception
would be more highly associated with measures of clin-
ical pain compared to heat pain perception, as previous
research has suggested that pressure sensitivity is highly
associated with musculoskeletal pain syndromes (Diat-
chenko et al., 2005; Rollman and Lautenbacher, 2001).
Since both momentary and average clinical pain were
assessed, we also examined whether evoked pain was
more highly associated with patients’ usual pain, or
more highly correlated with pain at the time of testing.2. Materials and methods
2.1. Subjects
Thirty-six subjects who met either the 1990 American
College of Rheumatology criteria for ﬁbromyalgia (FM)
(Wolfe et al., 1990), the diagnostic criteria for chronic
fatigue syndrome (CFS) (Fukuda et al., 1994), or both
diagnoses, were included in the study. Subjects with
CFS had to have at least one pain symptom to be eligi-
ble. Eight subjects were diagnosed with FM alone, eight
with CFS alone, and 20 fulﬁlled the diagnostic criteria
for both disorders. Twenty-seven were female, and nine
were male. Twenty-three were Caucasian, six were Afri-
can-American, two were Hispanic, two were Asian-
American, and three were of other descent. The mean
age was 39.6 (SD = 9.2) years. Mean duration of pain
was 96.5 months (SD = 80.9). Subjects with psychiatric
disorders that did not interfere with study participation
were not excluded.
The study was approved by the Georgetown Univer-
sity Medical Center’s institutional review board, and
informed consent was obtained from all participants
for study on the General Clinical Research Center. All
patients underwent a comprehensive screening during
which the diagnosis was conﬁrmed and co-morbidities
were evaluated. Exclusion criteria were severe physical
impairment, medical conditions that were capable of
causing patients’ symptoms (e.g., morbid obesity, auto-
immune/inﬂammatory diseases, cardiopulmonary disor-
ders), uncontrolled endocrine or allergic disorders (i.e.,
hyper-/hypothyroidism, diabetes, allergic rhinitis),
malignancy, severe psychiatric illnesses (e.g., schizophre-
nia, substance abuse), factors known to aﬀect the hypo-
thalamic pituitary axis (HPA) or autonomic function
(e.g., cigarette smoking, daily intake of caﬀeine exceed-
ing the equivalence of two cups of coﬀee), or medication
usage other than as-needed analgesics (excluding long-
term narcotics). We did not exclude subjects with psy-
chiatric conditions that are associated with HPA
dysfunction (e.g., major depression). Eleven subjects
who fulﬁlled the diagnostic criteria were excluded as
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examined in the current manuscript.
Subjects who qualiﬁed for inclusion in the study were
scheduled for a 2-day study protocol. They were asked
to discontinue intake of antidepressants up to four
weeks ahead of the appointment (depending on the
drug), but were allowed to use non-steroidal anti-inﬂam-
matory drugs until three days before the appointment.
On the ﬁrst day of the study, patients completed the
self-report questionnaires and were familiarized with
the pain testing paradigm. On the following day, they
participated in a pain psychophysical testing session.
2.2. Measures
2.2.1. Clinical pain
Clinical pain was assessed using the short-form of the
McGill Pain Questionnaire (MPQ; Melzack, 1987). This
questionnaire contains 15 pain adjectives, and a total
score is obtained by summing responses to all the items.
The present pain intensity (PPI) subscale was examined
as an indicator of pain intensity at the time of testing.
The scale is sensitive to change produced by various
pain interventions, and is highly correlated with the par-
ent scale (Melzack, 1987).
Self-report of clinical pain intensity was also obtained
by visual analogue scale (VAS) ratings. The scale was
100 mm long and anchored by the statements ‘‘no pain’’
on the left and ‘‘the most intense pain imaginable’’ on
the right. Separate VAS scales were used to measure
subjects’ level of pain on the day of testing and average
pain over the past month. VAS ratings have demon-
strated good reliability (Boeckstyns and Backer, 1989;
Revill et al., 1976) and concurrent validity when com-
pared to other methods of pain measurement (Downie
et al., 1978; Jensen et al., 1989).
2.2.2. Pressure and heat pain assessment
Evoked pain was assessed for both pressure and heat
stimuli. Pressure pain sensitivity was evaluated by sub-
jective scaling of pain sensations evoked by discrete 5-s
pressure stimuli applied to the ﬁxated left thumbnail
with a 1-cm2 hard rubber probe. Previous studies have
shown that ‘‘neutral’’ regions, such as the thumb, accu-
rately reﬂect an individual’s overall pressure pain sensi-
tivity (Petzke et al., 2001). The rubber probe was
attached to a hydraulic piston, which was connected
via a combination of valves to a second piston. Applica-
tion of calibrated weights to the second piston produced
controlled, repeatable pressure pain stimuli of rectangu-
lar waveform, that is, subjects experienced no pressure,
then the target stimulus pressure when the appropriate
weight was placed on the second piston. Subjects rated
the intensity and unpleasantness dimensions of pressure
pain sensations using a combined numerical (0–20) ana-
log descriptor scale (Gracely et al., 1979). For eachdimension, a series of 5-s stimuli were delivered to the
right thumbnail in ascending order in 0.5 kg of force
per square centimeter (kg/cm2) increments after an ini-
tial stimulus of 0.25 kg/cm2, up to a maximum of
10 kg/cm2. A second series of pressure stimuli was
administered using the multiple random staircase
(MRS) method (Gracely et al., 1988). A software system
uses the data collected from the ascending series to com-
pute starting stimulus intensities for another set of stim-
uli controlled by the method of MRS’s. The MRS is an
interactive system in which the software logic continu-
ously adjusts the stimulus intensity to maintain ratings
at several speciﬁc levels. In this implementation, three
independent staircases are titrated to produce pain sen-
sations rated between 0 and 1 (no sensation to faint
pain), between 9 and 10 (mild–moderate pain), and
between 13 and 14 (strong–slightly intense pain) on
the 0–20 box scale. In the remainder of this report, these
levels are referred to as low, medium, and high. On each
trial, the method randomly selects a staircase and deliv-
ers the stimulus intensity associated with that staircase.
The response determines the next stimulus delivered by
that staircase the next time it is selected. This determina-
tion is based on the previous response history and uses a
dynamically changing step size to estimate the stimulus
intensity required to produce the level of pain associated
with each particular staircase. The method will deliver
12 stimuli for each of the three staircases, for a total
of 36 stimuli delivered over 12 min. If any staircase
has not converged after 12 stimuli, the operator will be
able to continue the method until convergence is reached
or until 72 total stimuli have been delivered.
Heat pain sensations were evoked by a 1 cm diameter
contact thermode system. A low-mass electrical heater
on a water-perfused cold sink with feedback circuitry
delivered precise stimulus waveforms with a ramp rate
of 10 C/s. The thermal stimuli were delivered to the
volar surface of the non-IV forearm. As with the pres-
sure testing, both an ascending and a multiple random
staircase series of thermal stimuli were presented to each
subject. The temperatures required to evoke ratings of
low, medium, and high pain intensity and unpleasant-
ness were calculated for each subject.
2.2.3. Dolorimetry
A dolorimeter with a 1 cm2 tip was used to determine
pain threshold and tolerance levels bilaterally at the
thumb and lateral epicondyle. Pressure was increased
at a rate of 1 kg/cm2 per second and subjects were
instructed to indicate when they ﬁrst perceived pain
(threshold) and when the pain became unbearable (tol-
erance). Pressure was stopped once the pain became
unbearable or if 12 kg/cm2 of pressure was reached.
These sites were chosen as previous research has shown
that these points are highly correlated with overall ten-
derness (Petzke et al., 2001). The measures from each
Table 2
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each stimulus site.Measure McGill
total
VAS
past
month
PPI VAS
today
Dolorimeter
Lateral epicondyle threshold .36* .34* .17 .23
Lateral epicondyle tolerance .41* .35* .24 .30
Thumb threshold .22 .16 .09 .11
Thumb tolerance .31 .25 .20 .24
Pressure
Low intensity .42* .21 .18 .23
Medium intensity .48* .23 .22 .24
High intensity .52* .33* .27 .27
Low unpleasantness .30 .00 .13 .10
Medium unpleasantness .45* .19 .22 .16
High unpleasantness .52* .35* .27 .22
Heat
Low intensity .14 .18 .06 .11
Medium intensity .20 .31 .02 .17
High intensity .24 .31 .03 .15
Low unpleasantness .10 .07 .03 .00
Medium unpleasantness .20 .24 .01 .08
High unpleasantness .36* .35* .15 .17
* p < .05.3. Results
Table 1 shows the means and standard deviations for
pressure and thermal intensities needed to evoke sensa-
tions of mild, medium, and high sensory intensity and
unpleasantness using the random staircase procedure,
and displays the threshold and tolerance averages for
dolorimetry measured at the thumb and lateral
epicondyle.
An initial analysis examined whether the patient
groups diﬀered on any of the clinical or experimental
pain measures. Oneway analysis of variance (ANOVA)
revealed that the groups signiﬁcantly diﬀered on VAS
ratings of pain today (F = 7.0, p = .003) and pain over
the past month (F = 4.1, p = .03). Post hoc tests (Dun-
can) indicated that subjects diagnosed with both FM
and CFS had higher ratings of pain today compared
to the other two groups, and had higher VAS ratings
of pain over the past month compared to subjects diag-
nosed with CFS alone. In addition, the groups signiﬁ-
cantly diﬀered on pain threshold (F = 3.2, p = .05) and
tolerance (F = 3.2, p = .05) assessed by dolorimetry at
the lateral epicondyle. Post hoc tests revealed that sub-
jects with CFS alone had signiﬁcantly higher pain
threshold and tolerances compared to subjects with both
CFS and FM.
Correlations between the clinical pain measures,
dolorimetry, and heat and pressure pain measures (stim-
ulus intensities needed to evoke diﬀerent levels of pain
sensation) are presented in Table 2. The correlations
indicate that pressure stimuli delivered using the random
staircase method were signiﬁcantly associated with rat-
ings on the MPQ for both unpleasantness and intensityTable 1
Means (SD) of experimental heat and pressure measures
Measure Mean (SD)
Lateral epicondyle threshold (kg/cm2) 5.4 (2.5)
Lateral epicondyle tolerance (kg/cm2) 7.2 (3.0)
Thumb threshold (kg/cm2) 6.6 (3.0)
Thumb tolerance (kg/cm2) 8.2 (3.1)
Low pressure intensity (kg/cm2) 2.3 (1.8)
Medium pressure intensity (kg/cm2) 4.7 (2.5)
High pressure intensity (kg/cm2) 6.5 (2.7)
Low pressure unpleasantness (kg/cm2) 2.7 (2.3)
Medium pressure unpleasantness (kg/cm2) 5.4 (2.7)
High pressure unpleasantness (kg/cm2) 7.4 (2.9)
Low heat intensity (C) 38.3 (2.8)
Medium heat intensity (C) 43.0 (4.1)
High heat intensity (C) 46.9 (4.5)
Low heat unpleasantness (C) 39.3 (3.6)
Medium heat unpleasantness (C) 44.9 (4.8)
High heat unpleasantness (C) 48.2 (4.5)at all stimulus levels, with the exception of low unpleas-
antness ratings. In addition, pressure stimuli at high lev-
els of intensity and unpleasantness were signiﬁcantly
associated with VAS ratings of pain over the past
month. The magnitude of this association became
greater as the stimulus intensity increased. Measures of
pain threshold and tolerance assessed by dolorimetry
at the lateral epicondle were signiﬁcantly and inversely
related to the MPQ total score and average VAS over
the past month, indicating lower pain thresholds and
tolerance were signiﬁcantly associated with higher clini-
cal pain. Pain thresholds and tolerances measured at the
thumb using dolorimetry were not signiﬁcantly associ-
ated with these same measures. None of the dolorimetry,
heat or pressure pain measures were signiﬁcantly corre-
lated with measures of pain assessed on the day of
testing.
Measures of heat pain sensitivity delivered using the
random staircase procedure were not signiﬁcantly asso-
ciated with clinical pain ratings, with the exception of
high unpleasantness ratings and McGill total pain scores
and VAS ratings of pain over the past month.
To determine whether the signiﬁcant correlations
obtained between the experimental and clinical pain
measures signiﬁcantly diﬀered across experimental
methods, the formula for comparing two correlation
coeﬃcients from related samples was utilized (Weinberg
and Goldberg, 1979, p. 412). Comparing the associa-
tions between intensity and unpleasantness levels and
clinical pain assessed by the MPQ utilizing the MRS
pressure method versus heat, the associations with
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(t = 2.3, p = .03) and high (t = 2.8, p = .01) intensity
stimuli compared to the same levels obtained using
MRS heat. A similar result was also obtained for med-
ium (t = 2.1, p = .05) unpleasantness stimuli. When
VAS ratings of pain during the past month were exam-
ined, the associations between this measure and stimula-
tion levels obtained using MRS heat and MRS pressure
did not diﬀer. The correlations between dolorimetry and
clinical pain did not signiﬁcantly diﬀer from those
observed between MRS heat or pressure and clinical
pain. The magnitude of the associations between MRS
pressure and clinical pain, and dolorimetry and clinical
pain, were also not signiﬁcantly diﬀerent.
As trends were evident suggesting that higher stimu-
lation levels were more strongly associated with clinical
pain compared to less intense levels, these correlations
were also compared using the same method noted
above. For dolorimetry, associations between dolorime-
try and clinical pain comparing the threshold and toler-
ance measures did not signiﬁcantly diﬀer. For MRS
pressure and heat, the associations across diﬀerent inten-
sity rating levels also were not signiﬁcantly diﬀerent. For
unpleasantness ratings, the association between pressure
high unpleasantness and VAS ratings of pain over the
past month was signiﬁcantly greater than the association
between pressure low unpleasantness and this same mea-
sure of clinical pain (t = 2.8, p = .01). Also, the diﬀer-
ence in the associations between pressure low
unpleasantness and MPQ scores and high pressure
unpleasantness and MPQ scores approached signiﬁ-
cance (t  1.8, p = .08).4. Discussion
Pain sensitivity determined by pressure stimulation
using the multiple random staircase (MRS) procedure
was signiﬁcantly and inversely associated with average
measures of clinical pain intensity, while heat was not.
Comparing the magnitude of the associations, the corre-
lations between MRS measures of pressure and clinical
pain as assessed by the MPQ were signiﬁcantly higher
than those obtained between MRS heat and clinical
pain. None of the experimental pain measures were sig-
niﬁcantly associated with measures of clinical pain
assessed at the time of testing. These ﬁndings suggest
that responses to evoked pressure pain in patients with
FM and CFS can be generalized to patients’ overall clin-
ical condition, and that ﬂuctuations in clinical pain that
may occur during psychophysical testing do not signiﬁ-
cantly inﬂuence evoked pain responses. These ﬁndings
also suggest that pressure stimulation as an experimen-
tal pain model among subjects with FM and CFS more
closely reﬂects the average clinical pain associated with
these conditions, and is consistent with other researchsuggesting that mechanical stimulation is an especially
sensitive measure for the analysis of pathology associ-
ated with musculoskeletal pain (Diatchenko et al.,
2005; Rollman and Lautenbacher, 2001).
In general, ratings given to higher stimulus intensities
were more strongly associated with average ratings of
clinical pain. These ﬁndings highlight the importance
of evoked pain studies and provide further justiﬁcation
for the use of suprathreshold stimuli in experimental
pain paradigms. The ﬁndings also suggest that experi-
mental application of innocuous stimuli as a model for
clinical pain may not be as generalizable to clinical pain
conditions. In addition, the ﬁndings suggest that meth-
ods used to assess pain thresholds may not be as gener-
alizable to clinical pain compared to studies employing
suprathreshold methods of pain stimulation. This con-
clusion needs to be interpreted cautiously as signiﬁcantly
higher correlations between higher levels of experimen-
tal pain stimulation and clinical pain were only obtained
for unpleasantness ratings and not intensity ratings, and
this ﬁnding was only evident using the MRS pressure
stimulation method. Further research examining the
risk/beneﬁt of noxious stimulus intensities in relation
to the generalizability of the ﬁndings and subject burden
would be beneﬁcial.
Pressure stimulation using both dolorimetry and ran-
dom staircase methods were both signiﬁcantly associated
with average measures of clinical pain. However, our pre-
vious research suggests that random staircase methods
are less prone to biases associated with gradually ascend-
ing stimuli, and therefore are less likely to be inﬂuenced by
aﬀective states that frequently accompany pain, such as
depression. In the present study, the magnitude of the
associations between random staircase measures of pres-
sure sensation and clinical pain as assessed by the McGill
were somewhat higher than they were for dolorimetry,
although this diﬀerence was not statistically signiﬁcant.
Further research is needed to determine the types of
evoked pain models that most closely reﬂect the mecha-
nisms underlying diﬀerent clinical pain conditions.
It should be noted that the design of the present study
is cross-sectional, and therefore no inferences can be
made about causality. In addition, this study only exam-
ined a few of the experimental pain paradigms published
in the literature, and therefore the ﬁndings cannot speak
to the generalizability of other experimental methods to
clinical pain, such as electrical stimulation. Third, the
study examined patients with pain associated with FM
and CFS, and the ﬁndings may not be generalizable to
other clinical pain conditions. Fourth, this study exam-
ined the correlation between clinical pain intensity and
experimental pain perception, and did not examine the
ability of experimental methods to discriminate between
persons with and without chronic pain. Such a compar-
ison would also be beneﬁcial in examining the validity of
various methods of experimental pain.
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